Hormone therapy use and risk of ovarian cancer

JAMA

Volumn 302, Issue 20, 2009, Pages 2203-

  MacLennan, Alastair H ^a   Baber, Rodney ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; ECHOGRAPHY; HUMAN; LETTER; OBSERVER BIAS; OVARY CANCER; PELVIS; PRIORITY JOURNAL;

EID: 71849083058     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1724     Document Type: Letter

References (2)

1. Mørch LS, Løkkegaard E, Andreasen AH, Krüger- Kjær S, Lidegaard Ø. Hormone therapy and ovarian cancer. JAMA. 2009;302(3):298-305.
2. van Nagell JR Jr, DePriest PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer. 2007;109(9):1887-1896.